Simplex Trading’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,800
| Closed | -$21K | – | 8375 |
|
|
2025
Q3 | $21K | Buy |
+4,800
| New | +$14.2K | ﹤0.01% | 7272 |
|
|
2024
Q4 | – | Sell |
-7,400
| Closed | -$51K | – | 8386 |
|
|
2024
Q3 | $51K | Sell |
7,400
-2,900
| -28% | -$21.1K | ﹤0.01% | 5849 |
|
|
2024
Q2 | $70K | Sell |
10,300
-5,200
| -34% | -$48.4K | ﹤0.01% | 5733 |
|
|
2024
Q1 | $219K | Buy |
15,500
+15,290
| +7,281% | +$233K | ﹤0.01% | 4743 |
|
|
2023
Q4 | $1K | Sell |
210
-6,650
| -97% | -$60.7K | ﹤0.01% | 8419 |
|
|
2023
Q3 | $102K | Buy |
6,860
+4,630
| +208% | +$83.1K | ﹤0.01% | 5061 |
|
|
2023
Q2 | $35K | Sell |
2,230
-380
| -15% | -$4K | ﹤0.01% | 6170 |
|
|
2023
Q1 | $3K | Sell |
2,610
-21,240
| -89% | -$150K | ﹤0.01% | 8266 |
|
|
2022
Q4 | $138K | Hold |
23,850
| – | – | ﹤0.01% | 4686 |
|
|
2022
Q3 | $226K | Sell |
23,850
-12,800
| -35% | -$168K | ﹤0.01% | 4451 |
|
|
2022
Q2 | $439K | Sell |
36,650
-9,700
| -21% | -$102K | ﹤0.01% | 3594 |
|
|
2022
Q1 | $607K | Sell |
46,350
-12,580
| -21% | -$184K | ﹤0.01% | 3589 |
|
|
2021
Q4 | $1.04M | Buy |
58,930
+53,390
| +964% | +$1.07M | ﹤0.01% | 2807 |
|
|
2021
Q3 | $199K | Buy |
5,540
+570
| +11% | +$14.5K | ﹤0.01% | 5586 |
|
|
2021
Q2 | $173K | Buy |
4,970
+4,964
| +82,733% | +$267K | ﹤0.01% | 5916 |
|
|
2021
Q1 | $54K | Sell |
6
-3
| -33% | -$360 | ﹤0.01% | 6509 |
|
|
2020
Q4 | $97K | Buy |
9
+2
| +29% | +$247 | ﹤0.01% | 5466 |
|
|
2020
Q3 | $66K | Sell |
7
-5
| -42% | -$749 | ﹤0.01% | 5343 |
|
|
2020
Q2 | $244K | Buy |
12
+3
| +33% | +$531 | ﹤0.01% | 3775 |
|
|
2020
Q1 | $87K | Sell |
9
-42
| -82% | -$4.9K | ﹤0.01% | 4511 |
|
|
2019
Q4 | $589K | Sell |
51
-26
| -34% | -$2.29K | ﹤0.01% | 2586 |
|
|
2019
Q3 | $419K | Buy |
77
+76
| +7,600% | +$8.56K | ﹤0.01% | 2793 |
|
|
2019
Q2 | $7K | Sell |
1
-1
| -50% | -$83 | ﹤0.01% | 6276 |
|
|
2019
Q1 | $7K | Sell |
2
-2
| -50% | -$81 | ﹤0.01% | 6315 |
|
|
2018
Q4 | $12K | Sell |
4
-3
| -43% | -$122 | ﹤0.01% | 5707 |
|
|
2018
Q3 | $39K | Buy |
7
+6
| +600% | +$337 | ﹤0.01% | 5394 |
|
|
2018
Q2 | $7K | Sell |
1
-46
| -98% | -$2.77K | ﹤0.01% | 6514 |
|
|
2018
Q1 | $6K | Buy |
+47
| New | +$2.93K | ﹤0.01% | 4430 |
|
|
2015
Q4 | – | Sell |
-14
| Closed | -$11K | – | 5294 |
|
|
2015
Q3 | $11K | Sell |
14
-3
| -18% | -$383 | ﹤0.01% | 3319 |
|
|
2015
Q2 | $7K | Buy |
17
+16
| +1,600% | +$5.4K | ﹤0.01% | 3330 |
|
|
2015
Q1 | $2K | Buy |
+1
| New | +$423 | ﹤0.01% | 4022 |
|
Simplex Trading's ADVM Position: Q2 2025 in Review
Simplex Trading sold out of Adverum Biotechnologies (ADVM) in Q2 2025, closing a stake of 4,313 shares — an estimated $12.1K sold.
Simplex Trading first reported a position in ADVM in Q1 2015 and held it in 27 quarters. The position peaked at $1.78M in Q2 2020. 58 funds tracked by Wall St. Rank hold ADVM as of Q2 2025.
- Simplex Trading reported no remaining Adverum Biotechnologies position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 4,313 Adverum Biotechnologies shares in Q2 2025, an estimated $12.1K.
- Simplex Trading first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 27 quarters.
- Simplex Trading's Adverum Biotechnologies position peaked at $1.78M in Q2 2020.
- 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.